SLRX logo

Salarius Pharmaceuticals (SLRX) Company Overview

Profile

Full Name:

Salarius Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 29, 2015

Indexes:

Not included

Description:

Salarius Pharmaceuticals (SLRX) is a biotechnology company focused on developing innovative treatments for cancer. They specialize in targeted therapies that aim to improve patient outcomes and reduce side effects. Their research emphasizes precision medicine to address unmet medical needs in oncology.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 28, 2025

Recent annual earnings:

Feb 28, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jun 17, 2024

Analyst ratings

Recent major analysts updates

Mar 11, 22 HC Wainwright & Co.
Buy
Aug 25, 21 HC Wainwright & Co.
Buy
Jun 16, 20 Benchmark
Speculative Buy
Apr 27, 20 Ladenburg Thalmann
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Salarius Pharmaceuticals?
  • Does Salarius Pharmaceuticals pay dividends?
  • What sector is Salarius Pharmaceuticals in?
  • What industry is Salarius Pharmaceuticals in?
  • What country is Salarius Pharmaceuticals based in?
  • When did Salarius Pharmaceuticals go public?
  • Is Salarius Pharmaceuticals in the S&P 500?
  • Is Salarius Pharmaceuticals in the NASDAQ 100?
  • Is Salarius Pharmaceuticals in the Dow Jones?
  • When was Salarius Pharmaceuticals's last earnings report?
  • When does Salarius Pharmaceuticals report earnings?
  • Should I buy Salarius Pharmaceuticals stock now?

What is the ticker symbol for Salarius Pharmaceuticals?

The ticker symbol for Salarius Pharmaceuticals is NASDAQ:SLRX

Does Salarius Pharmaceuticals pay dividends?

No, Salarius Pharmaceuticals does not pay dividends

What sector is Salarius Pharmaceuticals in?

Salarius Pharmaceuticals is in the Healthcare sector

What industry is Salarius Pharmaceuticals in?

Salarius Pharmaceuticals is in the Biotechnology industry

What country is Salarius Pharmaceuticals based in?

Salarius Pharmaceuticals is headquartered in United States

When did Salarius Pharmaceuticals go public?

Salarius Pharmaceuticals's initial public offering (IPO) was on January 29, 2015

Is Salarius Pharmaceuticals in the S&P 500?

No, Salarius Pharmaceuticals is not included in the S&P 500 index

Is Salarius Pharmaceuticals in the NASDAQ 100?

No, Salarius Pharmaceuticals is not included in the NASDAQ 100 index

Is Salarius Pharmaceuticals in the Dow Jones?

No, Salarius Pharmaceuticals is not included in the Dow Jones index

When was Salarius Pharmaceuticals's last earnings report?

Salarius Pharmaceuticals's most recent earnings report was on Feb 28, 2025

When does Salarius Pharmaceuticals report earnings?

The date for Salarius Pharmaceuticals's next earnings report has not been announced yet

Should I buy Salarius Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions